Movement Alert｜Twist Bioscience Corp Falls 5.85% in Pre-Market Trading, Position Change Disclosure Keeps Volatility in Focus

Market Focus10-22

On October 22, Twist Bioscience Corp fell 5.85% in Pre-Market Trading, trading at $142.67 per share, with turnover of $391.1 thousand.

The move followed continued market focus on a disclosed change in holdings involving Laponis Adam, which has remained the clearest public event catalyst around the stock’s recent swings.

Background trading in recent sessions shows the same disclosure had already coincided with sharp two-way moves, including a 5.4% pre-market drop and a 5.16% rise in regular trading. Analyst views also remain mixed in the near term, with Jefferies initiating at Hold with a $150 price target and UBS initiating at Neutral with a $144 price target, underscoring ongoing valuation divergence as investors assess the company’s synthetic DNA and related tools businesses.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment